Innovation Pharmaceuticals Inc (IPIX)

[BonelessCat]

Here is what inclusion criteria states for treatment:
“Platinum resistant/refractory disease, defined as disease progression/relapse within 6 months following the last administered dose of platinum therapy (resistant), or lack of response or disease progression while receiving the most recent platinum based therapy (refractory), respectively”

Do we know if either or both were concurrently undergoing platinum treatment? I don’t recall seeing that in any report.